UPM-Kymmene gets 20 more EU days. UPM-Kymmene stock sits 13.64 percent below its 52-week high.

Published on 10/08/2026 at 14:35 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Second-quarter comparable EBIT rose 71.00 percent to EUR 212.00 million. UPM-Kymmene stock costs EUR 24.13 on October 8, 2026 after EUR 24.21.

Extreme Nahaufnahme von verflochtenen Holz- und Papierfasern mit feiner Textur — Makroaufnahme von Papierfasern illustriert die Rohstoffbasis von UPM-Kymmene Oyj, ISIN FI0009005987, in feiner Detailschärfe, Illustration mit AI erstellt.

UPM-Kymmene (ISIN FI0009005987) was trading at EUR 24.13 at Lang & Schwarz on October 8, 2026 at 2:31 p.m. CEST, 13.64 percent below its 52-week high of EUR 27.94. The company received 20 additional days to propose remedies for its EUR 1.42 billion paper joint venture, with the new European Union deadline set for December 9, 2026, according to Reuters on October 6, 2026.

EU review adds a new deadline

The additional 20 days give UPM and Sappi until December 9 to address competition concerns over their proposed communication-paper combination. The companies plan to submit remedies without divestments, while the European Commission has warned that the transaction could restrict competition in communication paper markets, Reuters reported.

UPM said on October 5, 2026, that the Commission had restated serious concerns in a Letter of Facts. In its release, UPM said the parties signed the definitive agreement in May 2026 and that a final decision was expected by year-end or shortly afterward.

What does the review mean for earnings?

The regulatory timetable matters because the joint venture would reshape UPM's communication-paper operations, while the group is also preparing a separate plywood transaction. The deal value of EUR 1.42 billion provides a concrete measure of the asset combination, but the remedy process leaves the closing timetable dependent on the Commission's decision.

Continuing operations reported comparable EBIT of EUR 212.00 million in the second quarter of 2026, up 71.00 percent year over year, on revenue of EUR 2.355 billion, according to Packaging News Daily. The comparable EBITDA margin was 15.10 percent, compared with 10.70 percent a year earlier, giving investors a measurable operating counterweight to the regulatory risk.

Three milestones lead into November

On September 18, 2026, Finland's Financial Supervisory Authority approved a supplement to the WISA demerger and listing prospectus, with the planned completion date set for October 31, 2026, according to UPM. On October 5, 2026, UPM disclosed the European Commission's renewed concerns over the EUR 1.42 billion joint venture. On October 6, 2026, Reuters reported the additional 20-day remedy period ending December 9, 2026.

Upcoming dates for UPM

UPM's next reporting date is October 28, 2026, according to Simply Wall St. The WISA demerger is planned for October 31, 2026, and WISA shares are expected to begin trading on Nasdaq Helsinki on November 2, 2026, according to UPM.

UPM-Kymmene stock remains below its high

At EUR 24.13, the Lang & Schwarz price was EUR 0.08 below the prior close of EUR 24.21 on October 7, 2026, a decline of 0.33 percent. The quoted market capitalization was EUR 12.7 billion and the 52-week range was EUR 21.72 to EUR 27.94 as of October 8, 2026. The further course of trading is shown by the continuously updated real-time quote of UPM-Kymmene stock.